Section of Otorhinolaryngology-Head and Neck Surgery, Azienda Ospedaliera di Padova, University of Padua, Padua, Italy; Unit of Otorhinolaryngology-Head and Neck Surgery, Azienda Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
Unit of Otorhinolaryngology-Head and Neck Surgery, Azienda Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
Oral Oncol. 2021 Jan;112:105043. doi: 10.1016/j.oraloncology.2020.105043. Epub 2020 Oct 14.
Preoperative screening had a key role in planning elective surgical activity for head and neck cancer (HNC) during the COVID-19 pandemic.
All patients undergoing surgery for HNC at two Italian referral hospitals (University of Padua and National Cancer Institute [NCI]) during the peak of the COVID-19 epidemic in Italy were included. Accuracy of screening protocols was assessed.
In the Padua protocol, 41 patients were screened by pharyngeal swab. The entire sample (100%) was admitted to surgery, diagnostic accuracy was 100%. In the NCI protocol, 23 patients underwent a telephone interview, blood test, and chest CT. Twenty patients (87%) were negative and were directly admitted to surgery. In the remaining 3 (13%), pharyngeal swab was performed. The screening was repeated until a negative chest CT was found. Diagnostic accuracy was 85%.
Dedicated screening protocols for COVID-19 allow to safely perform elective HNC surgery.
在 COVID-19 大流行期间,术前筛查在规划头颈部癌症(HNC)择期手术中起着关键作用。
纳入了在意大利 COVID-19 疫情高峰期在两家意大利转诊医院(帕多瓦大学和国家癌症研究所[NCI])接受 HNC 手术的所有患者。评估了筛查方案的准确性。
在帕多瓦方案中,有 41 例患者通过咽拭子筛查。整个样本(100%)均接受手术,诊断准确性为 100%。在 NCI 方案中,23 例患者接受了电话访谈、血液检查和胸部 CT。20 例(87%)为阴性并直接接受手术。其余 3 例(13%)进行了咽拭子检查。重复进行筛查,直到发现阴性的胸部 CT 为止。诊断准确性为 85%。
针对 COVID-19 的专用筛查方案可安全地进行 HNC 择期手术。